Emergent BioSolutions to Participate in Investor Conferences
Get Alerts EBS Hot Sheet
Join SI Premium – FREE
GAITHERSBURG, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences:
- 12th Annual Midwest IDEAS Investor ConferenceChicago, ILAugust 24, 2022 – presentation scheduled at 5:15 PM central time https://www.wsw.com/webcast/threepa38/ebs/2021448
- Wells Fargo 2022 Healthcare ConferenceBoston, MASeptember 8, 2022 – fireside chat scheduled at 9:10 AM eastern time
- Wells Fargo 2022 Leveraged Finance ConferenceNashville, TNSeptember 8, 2022 – fireside chat scheduled at 2:30 PM central time
- Morgan Stanley 20th Annual Global Healthcare ConferenceNew York, NYSeptember 12-14, 2022 – presentation date and time will be updated on the Emergent website as the information becomes available
For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.
About Emergent BioSolutionsAt Emergent, our mission is to protect and enhance life. For over 20 years, we’ve been at work defending people from things we hope will never happen—so we are prepared, just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280[email protected]
Media Contact:Matt HartwigSenior Director, Media Relations[email protected]
Source: Emergent BioSolutionsSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- FSI ANNOUNCES FIRST QUARTER 2024 REVENUE
- Eastgroup Properties (EGP) Tops Q1 EPS by 17c, provides guidance
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Morgan Stanley, Twitter, Earnings, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!